Literature DB >> 2840952

Phenylalanine hydroxylase deficiency caused by a single base substitution in an exon of the human phenylalanine hydroxylase gene.

U Lichter-Konecki1, D S Konecki, A G DiLella, K Brayton, J Marvit, T M Hahn, F K Trefz, S L Woo.   

Abstract

A novel restriction fragment length polymorphism in the phenylalanine hydroxylase (PAH) locus generated by the restriction endonuclease MspI was observed in a German phenylketonuria (PKU) patient. Molecular cloning and DNA sequence analyses revealed that the MspI polymorphism was created by a T to C transition in exon 9 of the human PAH gene, which also resulted in the conversion of a leucine codon to a proline codon. The effect of the amino acid substitution was investigated by creating a corresponding mutation in a full-length human PAH cDNA by site-directed mutagenesis followed by expression analysis in cultured mammalian cells. Results demonstrate that the mutation in the gene causes the synthesis of an unstable protein in the cell corresponding to a CRM- phenotype. Together with the other mutations recently reported in the PAH gene, the data support previous biochemical and clinical observations that PKU is a heterogeneous disorder at the gene level.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840952     DOI: 10.1021/bi00408a032

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Linkage disequilibrium between phenylketonuria and RFLP haplotype 1 at the phenylalanine hydroxylase locus in Portugal.

Authors:  C Caillaud; L Vilarinho; A Vilarinho; F Rey; M Berthelon; R Santos; S Lyonnet; M L Briard; R V Osorio; J Rey
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

Review 2.  Heterogeneity of phenylketonuria at the clinical, protein and DNA levels.

Authors:  R G Cotton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Molecular heterogeneity at the phenylalanine hydroxylase locus in the population of the south-west of England.

Authors:  L A Tyfield; M J Osborn; J B Holton
Journal:  J Med Genet       Date:  1991-04       Impact factor: 6.318

Review 5.  Molecular genetics of phenylketonuria and its implications.

Authors:  H L Levy
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

6.  Identification of the haplotype pattern associated with the mutant PKU allele in the Gypsy population of Wales.

Authors:  L A Tyfield; A L Meredith; M J Osborn; P S Harper
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

7.  Novel PKU mutation on haplotype 2 in French-Canadians.

Authors:  S W John; R Rozen; R Laframboise; C Laberge; C R Scriver
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

8.  Severity of mutation in the phenylalanine hydroxylase gene influences phenylalanine metabolism in phenylketonuria and hyperphenylalaninaemia heterozygotes.

Authors:  E Svensson; L Iselius; L Hagenfeldt
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria.

Authors:  P Burgard; A Rupp; D S Konecki; F K Trefz; H Schmidt; U Lichter-Konecki
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 10.  Clinical application of genotypic diagnosis for phenylketonuria: theoretical considerations.

Authors:  F D Ledley
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.